![Carolina Trkulja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carolina Trkulja
Amministratore Delegato presso
FLUICELL AB
Profilo
Carolina Trkulja is the founder of Oblique Therapeutics AB. Dr. Trkulja is currently the Chief Executive Officer at Fluicell AB since 2023.
Dr. Trkulja holds a doctorate degree from Chalmers University of Technology.
Posizioni attive di Carolina Trkulja
| Società | Posizione | Inizio |
|---|---|---|
| FLUICELL AB | Amministratore Delegato | 01/01/2023 |
Precedenti posizioni note di Carolina Trkulja
| Società | Posizione | Fine |
|---|---|---|
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Fondatore | - |
Formazione di Carolina Trkulja
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluicell AB
 Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
